US20070239216A9 - Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue - Google Patents

Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue Download PDF

Info

Publication number
US20070239216A9
US20070239216A9 US10/116,201 US11620102A US2007239216A9 US 20070239216 A9 US20070239216 A9 US 20070239216A9 US 11620102 A US11620102 A US 11620102A US 2007239216 A9 US2007239216 A9 US 2007239216A9
Authority
US
United States
Prior art keywords
stimulation
pulse
generating
apparatus
method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/116,201
Other versions
US8825152B2 (en
US20030040777A1 (en
Inventor
Itzik Shemer
Bella Felzen
Nissim Darvish
Yuval Mika
Walid Haddad
Ricardo Aviv
Yaakov Haham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Impulse Dynamics NV
Original Assignee
Impulse Dynamics NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL116,699 priority Critical
Priority to IL116699 priority
Priority to IL11669996A priority patent/IL116699A/en
Priority to US976996P priority
Priority to US08/595,365 priority patent/US5738096A/en
Priority to US1111796P priority
Priority to US2639296P priority
Priority to IL11926196A priority patent/IL119261D0/en
Priority to IL119,261 priority
Priority to IL119261 priority
Priority to PCT/IL1997/000012 priority patent/WO1997025098A1/en
Priority to US09/101,723 priority patent/US6317631B1/en
Priority to US15751199P priority
Priority to US09/563,544 priority patent/US6363279B1/en
Priority to PCT/IB2000/001523 priority patent/WO2001024871A2/en
Priority to US10/039,845 priority patent/US9289618B1/en
Priority to US10/116,201 priority patent/US8825152B2/en
Application filed by Impulse Dynamics NV filed Critical Impulse Dynamics NV
Publication of US20030040777A1 publication Critical patent/US20030040777A1/en
Assigned to IMPULSE DYNAMICS N.V. reassignment IMPULSE DYNAMICS N.V. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AVIV, RICHARDO, MIKA, YUVAL, DARVISH, NISSIM, FELZEN, BELLA, HADDAD, WALID, HAHAM, YAAKOV, SHERMER, ITZIK
Assigned to DRUMBEAT LIMITED reassignment DRUMBEAT LIMITED SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IMPULSE DYNAMICS N.V.
Assigned to BANK HAPOALIM B.M. reassignment BANK HAPOALIM B.M. SECURITY AGREEMENT Assignors: IMPULSE DYNAMICS N.V.
Assigned to JOHNSON & JOHNSON DEVELOPMENT CORPORATION reassignment JOHNSON & JOHNSON DEVELOPMENT CORPORATION SECURITY AGREEMENT Assignors: IMPULSE DYNAMICS N.V.
Publication of US20070239216A9 publication Critical patent/US20070239216A9/en
Assigned to MEDINVEST CAPITAL S.A R.L. reassignment MEDINVEST CAPITAL S.A R.L. SECURITY AGREEMENT Assignors: IMPULSE DYNAMICS N.V.
Application granted granted Critical
Publication of US8825152B2 publication Critical patent/US8825152B2/en
Assigned to SANDLEFORD PARK LIMITED, AS SECURITY AGENT reassignment SANDLEFORD PARK LIMITED, AS SECURITY AGENT ASSIGNMENT OF TRADEMARK AND PATENT SECURITY AGREEMENT Assignors: MEDINVEST CAPITAL S.A.R.L., MORGAN STANLEY BANK INTERNATIONAL LIMITED
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3627Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3628Heart stimulators using sub-threshold or non-excitatory signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions

Abstract

According to a method and device for modulating intracellular calcium concentration in biological tissue, a stimulation probe is applied to the tissue, a non-excitatory stimulation pulse is generated, and the pulse is conveyed to the stimulation probe. In one embodiment concerning cardiac tissue, a stimulation probe is applied to a patient's heart, a signal is received from at least one sensor responsive to the patient's cardiac muscle activity, a non-excitatory stimulation pulse responsive to the signal is generated, and the pulse is conveyed to the stimulation probe.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application claims the benefit of U.S. Provisional Patent Application Serial No. 60/157,511, filed Oct. 4, 1999, which is assigned to the assignee of the present patent application and is incorporated herein by reference.
  • FIELD OF THE INVENTION
  • This invention relates generally to invasive devices and methods for treatment of the heart, including devices and methods for stimulation of the heart muscle. More particularly, this invention relates to control of cellular tissue, specifically the modulation of intracellular calcium concentration in cardiac muscle cells.
  • BACKGROUND OF THE INVENTION
  • Cardiac insufficiency, characterized inter alia by a reduction in cardiac output, is a common, well-known and well-documented heart malfunction. It develops as a result of congenital defects or as an end-effect of many diseases. Cardiac output, i.e., the output of the heart per unit time, is the product of stroke volume and heart rate. Hence, variations in cardiac output can be produced by changes in cardiac rate or stroke volume. The stroke volume can be influenced, for example, by changing the strength of cardiac contraction, by changing the length of the cardiac muscle fibers, and by changing contractility of cardiac muscle independent of fiber length. The heart rate and rhythm influence the cardiac output both directly and indirectly, since changes in the rate and rhythm also affect myocardial contractility.
  • The human body normally regulates the cardiac output in response to body needs by changing the heart rate, as during physical exercise, and/or by adapting the stroke volume. Under pathological conditions, however, some of the normal regulatory mechanisms may be damaged. For example, heart tissue damaged due to-myocardial infarct typically cannot sustain normal pumping function, leading to a reduction in stroke volume, and hence of cardiac output. The body may react to such a reduction by increasing the heart rate, thus imposing long term strain on the heart muscles, leading in more severe cases to heart failure. There is thus a need for devices and treatments that can regulate the cardiac output, so as to compensate for the deficiencies in the normal regulation mechanisms.
  • In response to this need, modern cardiology has developed means to control various parameters associated with the heart's operation. Pharmaceuticals, for example, may be used to influence the conduction velocity, excitability, contractility and duration of the refractory period of the heart tissue. These pharmaceuticals are used to treat arrhythmia, enhance cardiac output and prevent fibrillation. Pharmaceuticals are generally limited in effectiveness in that they affect both healthy and diseased segments of the heart, usually, with a relatively low precision. They frequently also have unwanted side-effects.
  • A special kind of control can be achieved using implantable electronic devices, which provide excitatory electrical stimulation to the heart to control directly the heart rate and/or rhythm. For example, a pacemaker, an electronic device which is typically implanted in the heart to support the heart's electrical excitation system or to bypass a blocked portion of the conduction system. Another type of cardiac electronic device is a defibrillator, which senses fibrillation in the heart and applies a high voltage impulse to “reset” the heart. While electronic pacemakers can control the heart rate, however, they are limited in their capacity to enhance cardiac output, and they are known to reduce stroke volume in at least some instances. Defibrillators are useful in treating arrhythmia when it occurs (although they are painful to the patient and traumatic to the heart), but they provide no long-term amelioration of cardiac insufficiency.
  • Thus, none of the treatments known in the art allow effective, long-term regulation of cardiac output. PCT patent application PCT/IL97/00012, published as WO 97/25098, to Ben-Haim et al., which is incorporated herein by reference, describes methods for modifying the force of contraction of at least a portion a heart chamber by applying a non-excitatory electric field to the heart at a delay after electrical activation of the portion. The non-excitatory field is such as does not induce new activation potentials in cardiac muscle cells, but rather modifies the cells' response to the activation.
  • OBJECTS OF THE INVENTION
  • It is an object of some aspects of the present invention to provide improved methods and apparatus for controlling calcium concentration in biological tissue.
  • It is also an object of the present invention to provide methods and apparatus for modulating intracellular calcium concentration in cardiac tissue.
  • It is a further object of the present invention to provide methods and apparatus for modulating cardiac contractibility.
  • These and other objects of the invention will become more apparent form the discussion below.
  • SUMMARY OF THE INVENTION
  • In preferred embodiments of the present invention, a controller comprises a non-excitatory stimulation probe, including one or more non-excitatory stimulation electrodes, at least one sensor, preferably a sensing electrode; and electronic control circuitry, coupled to the stimulation probe and sensor. The stimulation electrodes and, preferably, the sensor are implemented in the heart. Alternatively, a sensing electrode may be placed on a body surface. The circuitry receives signals from the sensor, indicative of the heart's activity, and responsive thereto, drives the stimulation electrodes to provide non-excitatory electrical stimulation to the heart. A non-excitatory electrical field, current or voltage is passed through biological tissue, such as cardiac tissue, or in its proximity, resulting in either changing trans-membranal calcium ion fluxes or and/or intracellular stores content.
  • The term “non-excitatory electrical stimulation” (“IDS”) in the context of the present patent application and in the claims, refers to electrical pulses that do not induce new activation potentials to propagate in cardiac muscle cells. Rather, such pulses generally affect the response of the heart muscle to the action potentials, possibly by modulating cell contractility within selected segments of the cardiac muscle.
  • In any case, the effect of the device on intracellular calcium concentration is preferably regulated by changing the timing of the non-excitatory stimulation pulse relative to the heart's activity, preferably relative to the heart's local electrical activity or ECG signals received by the sensing electrode, and/or by changing other pulse characteristics, such as voltage, current, duration, polarity, waveform and frequency of the waveform. Preferably, the device senses the heart's sinus rhythm and applies and synchronizes the stimulation pulse relative thereto, preferably with a delay before the onset of the stimulation pulse. Additionally, the circuitry may analyze the signals, for example, to determine the QT interval, so as to adjust the stimulation pulses responsive thereto. Alternatively, when the heart's rhythm is irregular, due to ventricular premature beats (VPB's) or other cardiac arrhythmias, the device preferably identifies and analyzes the irregularity, using signal processing methods known in the art, and adjusts or withholds the stimulation pulse accordingly.
  • In some preferred embodiments of the present invention the control circuitry is contained within a console external to the body, and the electrodes are fed percutaneously into the subject's vascular system, for example, through the femoral artery, and are implanted in the heart. Such embodiments are useful particularly in short-term therapy to regulate and stabilize the subject's hemodynamics following an insult or trauma, for example, open heart surgery or MI.
  • In alternative preferred embodiments of the present invention, the electronic control circuitry is contained within a miniaturized, implantable case, similar to pacemaker cases known in the art
  • In some preferred embodiments of the present invention, the non-excitatory stimulation electrodes known in the art, such as pacing or electrophysiology electrodes. Preferably, the stimulation electrodes comprise large-area carbon electrodes or any other metal electrodes such as titanium nitrate, iridium oxide, most preferably vitreous carbon, or alternatively, pyro-carbon. Both types of carbon materials are known for their compatibility with heart tissue, in-vivo durability and excellent electrical properties, including high electrical conductivity. Thus, they allow a relatively high electrical current to be delivered to a relatively large segment of the heart tissue, without inducing electrical excitation.
  • In other preferred embodiments of the present invention, the non-excitatory stimulation electrodes are inserted into one of the blood vessels of the heart, preferably into the coronary sinus, or alternatively, into a coronary artery.
  • In another preferred embodiment of this type, different stimulation pulses are applied to respective ones or groups of the plurality of stimulation electrodes. Preferably, the different stimulation pulses are applied to the respective electrodes with a predetermined delay between the different pulses. The delay may be varied so as to achieve a desired hemodynamic effect, for example, to maximize the increase in stroke volume.
  • In still other such preferred embodiments, the positions of the plurality of stimulation electrodes and/or characteristics of the stimulation pulses applied thereto are optimized responsive to clinical characteristics of the heart. Preferably, before insertion of the electrodes, a map of the heart is produced, for example, an electrophysiological map, as described in U.S. Pat. No. 5,568,809, or a phase-dependent geometrical map, as described in PCT Patent Application PCT/IL97/00011, both of which are incorporated herein by reference. Preferably, the map includes information regarding the viability of the heart tissue, for example, based on local contractility or electrical activity. The non-excitatory stimulation electrodes are then positioned responsive to the map.
  • Preferably, applying the IDS signal includes conveying electrical energy to cells of the heart, such that action potentials are generally not generated in the cells responsive to the application of the non-excitatory signal.
  • Further preferably, the IDS signal is applied to improve hemodynamic performance of the heart. Preferably, the IDS signal is applied in order to increase contractility of the heart or, alternatively or additionally, to increase systolic pressure generated by the heart
  • In a preferred embodiment, applying the IDS signal includes sensing physiological variables and applying the signal responsive thereto. Preferably, sensing the variable includes detecting an electrical depolarization wave in the tissue. Alternatively, sensing the variable includes sensing a hemodynamic parameter. Preferably, applying the pacing pulses include controlling application of the pacing pulses responsive to the variable, wherein controlling the application of the pacing pulses includes making a transition from a first stimulation mode to a second stimulation mode responsive to the variable.
  • There is also provided, in accordance with a preferred embodiment of the present invention, apparatus for stimulating cardiac tissue, including:
      • a plurality of electrodes, which are placed at multiple sites in at least two different chambers of the heart; and
      • an electrical control unit, which applies pacing pulses to two or more of the electrodes at respective pacing sites in the at least two different chambers, and which applies an IDS signal to at least one of the electrodes in a vicinity of one or more of the pacing sites following application of the pacing pulse at the site.
  • Preferably, the at least one of the electrodes to which the IDS signal is applied includes one of the electrodes to which the pacing pulses are applied.
  • Further preferably, at least one of the pacing sites is in the left ventricle, and the IDS signal is applied to an electrode in the left ventricle.
  • Preferably, the control unit applies the IDS signal between during a time period which begins between about 0 and 100 ms after the onset of a pacing pulse applied by the control unit, wherein the time period is set so as to substantially eliminate the possibility that a propagating action potential will be generated responsive to application of the IDS signal. Preferably, the time period begins between about 10 and 50 ms after the onset of the pacing pulse.
  • Preferably, the IDS signal is applied in order to increase contractility of the heart or, alternatively or additionally, in order to increase systolic pressure generated by the heart.
  • In a preferred embodiment, the apparatus includes a sensor, which senses a physiological variable, wherein the control unit receives an input from the sensor and applies the IDS signal responsive thereto. Preferably, the sensor detects an electrical depolarization wave in the tissue. Alternatively (or additionally, the sensor senses a hemodynamic: parameter or senses motion. Preferably, the control unit controls application of the pacing pulses responsive to the variable. Further preferably the control unit makes a transition from a first stimulation mode to a second stimulation mode responsive to the variable.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The present invention will be more fully understood form the following detailed description of the preferred embodiments thereof, taken together with the drawings, in which:
  • FIG. 1A is a graph of shortening vs. time, before, during, and after an IDS signal;
  • FIG. 1B is a graph of calcium concentration vs. time;
  • FIG. 2A is a graph of calcium concentration vs. time;
  • FIG. 2B is a graph of shortening vs. time;
  • FIG. 3 depicts two graphs vs. time, graph (a) representing concentration form vs. time, and graph (b) represents action potential vs. time; and
  • FIG. 4 depicts two graphs of concentration force vs. time, (a) being a control and (b) representing the use of a drug.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • This invention is designed to modulate intracellular calcium concentration in a biological tissue using a non-excitatory electrical signal (IDS). In particular, the invention relates to the modulation of the intracellular calcium in cardiac muscle cells and thus the modulation of cardiac contractility. According to this invention a non-excitatory electrical field, current or voltage is passed through the tissue or in its proximity, resulting in either changing trans-membranal calcium ion fluxes or an intracellular calcium stores content. In another aspect of the invention the electrical field may interfere/enhance the affinity of intracellular calcium binding elements to calcium. In a further aspect the rise in intracellular calcium concentrations may initiate a cascade of events including, but not limited to, phosphorylation/dephosphorylation, gene transcription, and/or post translation modification.
  • Systems are disclosed which utilize the application of electrical current to a tissue, effecting tissue contractility by means of modulating intracellular calcium. At least one pair of electrodes is used for applying the signal. Electrode placement is adapted for achieving the maximum desired effect. The electrodes are attached to an either implantable or external device with programming capabilities. This device can be tested and calibrated non-invasively by external mechanisms. In addition, stimulation parameters can be adjusted by a similar programming mechanism.
  • The characteristics of the electrodes used for the stimulation are important. This invention utilizes both uni-polar and bi-polar electrode configurations.
  • A novel aspect of this method of modulating intracellular calcium in cells is the ability to adjust the timing and the amount of calcium increase/decrease using temporal electrical current rather than systemic pharmacological agents.
  • The accompanying figures show changes in intracellular calcium resulting from the application of the IDS signal together with experimental evidence on the effect of the IDS signal on the calcium handling in the cell. FIG. 1A represents the shortening of a single isolated myocyte measured using optical means. Each of the lines represents a single contraction of the myocyte. When the IDS signal was delivered, a marked increase in the myocyte shortening of 30.9±5% (n=10) was observed. The shortening returned to baseline when signal delivery was stopped.
  • FIG. 1B shows the optical measurements of calcium concentration from a single myocyte without the application of the IDS signal (dark line) and on top of it superimposed the intracellular calcium concentration during the delivery of the IDS signal (gray line). An increase of 26.6% (n=3) in the peak calcium level was observed. The calcium concentration changes were measured using the florescence ration of a calcium sensitive dye Fura-2 at two wavelengths, 340 nm and 380 nm. The same result showing a large increase in calcium concentration was measured from an isolated ferret heart using a Langendorf setting. The ventricle contraction force and contractility increased by up to 50%, and at the same time cellular calcium concentration, measured using Aquarine calcium sensitive dye, was increased by up to 50%.
  • FIGS. 2A and 2B show the effect of the IDS signal on the shortening and intracellular calcium of myocytes isolated from canine heart with heart failure (generated by repeated ischemia events). Each line represents an average of 20 consecutive beats before (black line) and during (gray line) the application of the signal. FIG. 2A shows an increase of 24.9±3.9% (n=11) in shortening. FIG. 2B shows an increase of 29.7% (n=3) in intracellular calcium measured using Fluo-3 fluorescence.
  • FIG. 3 depicts initial changes in contraction force and in action potential duration, measured using an intracellular electrode, during the first three beats of IDS signal application to a rabbit papillary muscle. The action potential duration when the IDS signal is applied (gray line in the lower trace) is superimposed on a control contraction (black line in the middle trace). Black lines, in the upper trace, mark the start of application of the IDS signal. The action potential duration immediately changes upon the application of the IDS signal from the first pulse. There is no significant difference between action potential duration in the consecutive beats. The contraction force behaves differently; there is a small increase in the contraction force on the first beat followed by a larger increase in the second beat and gradual changes until a plateau is reached after 5 to 6 beats. The underlying mechanism is that the IDS signal prolongs action potential duration. As a result of action potential prolongation the flow of calcium into the cell increases and generates two effects:
      • (1) immediate increase in the Sarcolemal calcium level causing the initial increase in the contraction force on the first beat; and
      • (2) increase in the stored calcium in the Sarcoplasmatic Reticulum (SR) that is released during the following contractions and induces a larger increase in contraction until a new steady state is reached with higher contraction force.
  • The initial increase in the contractile force also supports the possible increase in the affinity of intracellular calcium binding elements that cause part of the increase in the contraction force.
  • FIG. 4 provides additional evidence supporting the hypothesis of calcium entry. The lower trace shows the increase in contraction force of a rabbit papillary muscle as a result of an IDS signal (shown as a black line on the upper trace). The initial increase in contraction on the first beat followed by the gradual change in the following beats is clearly seen. The middle trace shows the change in contraction force of the same muscle after the addition of the Ryanodine to the bath solution. Ryanodine prevents the accumulation of calcium in the Sarcoplasmatic Reticulum and therefore decreases the baseline contraction force. Upon the application of the IDS signal the contraction force increases immediately on the first beat, but no increase occurs during the following beats since the SR mechanism is disabled by the Ryanodine and no accumulation of calcium in the SR can contribute to the additional increase in contraction force exist.
  • All such variations, applications and subcombinations of elements are considered to be within scope of the present invention. It will thus be appreciated that the preferred embodiments described above are cited by way of example, and the full scope of the invention is limited only by the claims.

Claims (58)

1. A method of modulating intracellular calcium concentration in biological tissue, which comprises the steps of:
(a) applying a stimulation probe to biological tissue;
(b) generating a non-excitatory stimulation pulse; and
(c) conveying the pulse to the stimulation probe.
2. The method of claim 1, wherein the stimulation probe comprises one or more stimulation probes.
3. The method of claim 1, wherein the intracellular calcium concentration is increased.
4. The method of claim 1, wherein the intracellular calcium concentration is decreased.
5. A method of modulating intracellular calcium concentration in cardiac tissue, comprising:
(a) applying a stimulation probe comprising one or more stimulation electrodes to a subject's heart;
(b) receiving a signal from at least one sensor responsive to the subject's cardiac muscle activity;
(c) generating a non-excitatory stimulation pulse responsive to the signal; and
(d) conveying the pulse to at least one of the one or more electrodes.
6. The method of claim 5, wherein the intracellular calcium concentration is increased.
7. The method of claim 5, wherein the intracellular calcium concentration is decreased.
8. The method of claim 5, wherein receiving the signal comprises introducing a sensing electrode into the heart and receiving signals therefrom, and wherein generating the stimulation pulse comprises generating a pulse synchronized with electrical activity sensed by the sensing electrode.
9. The method of claim 5, wherein receiving the signal comprises applying an electrode to a body surface and receiving signals therefrom, and wherein generating the stimulation pulse comprises generating a pulse synchronized with an ECG signal.
10. The method of claim 5, wherein receiving the signal comprises receiving signals from at least one of the one or more stimulation electrodes.
11. The method of claim 5, wherein generating the stimulation pulse comprises generating a pulse having a predetermined delay relative to the signal.
12. The method of claim 5, wherein applying the stimulation probe comprises applying a probe comprising a plurality of stimulation electrodes, and wherein generating and conveying the pulse comprises generating a sequence of pulses and applying each pulse in the sequence to a different one of the plurality of stimulation electrodes.
13. The method of claim 5, wherein generating and conveying the stimulation pulse comprises generating and conveying stimulation pulses selectively, based on a characteristic of the signals received from the at least one sensor.
14. The method of claim 13, wherein generating and conveying the pulses comprises generating and applying pulses at a rate dependent on the heart rate, but not equal to the heart rate.
15. The method of claim 13, wherein generating and conveying the pulses comprises detecting a cardiac arrhythmia and adjusting the application of the pulses responsive thereto.
16. The method of claim 13, wherein generating and conveying the pulses comprises detecting a QT interval in the signals and generating pulses responsive thereto.
17. The method of claim 5, wherein generating the non-excitatory stimulation pulse comprises varying one or more parameters of the pulse, selected from the group consisting of the pulse voltage, current, duration, delay, and waveform frequency.
18. The method of claim 5, wherein the pulse comprises a baseline pulse and a waveform of substantially higher frequency than the baseline pulse superimposed thereon.
19. The method of claim 18, wherein the waveform comprises a square wave.
20. The method of claim 5, and comprising, after generating and conveying the non-excitatory stimulation pulse, generating and conveying another pulse of opposite polarity thereto.
21. The method of claim 5, wherein applying the non-excitatory stimulation pulse comprises varying the extent of a portion of the area of the heart segment to which the stimulation pulse is applied.
22. The method of claim 21, wherein varying the extent comprises selectively addressing a net of stimulation electrodes implanted in the heart.
23. The method of claim 5, wherein applying the stimulation probe comprises inserting the one or more stimulation electrodes into multiple chambers of the heart.
24. The method of claim 5 wherein implanting the stimulation probe comprises inserting at least one of the one or more stimulation electrodes into a blood vessel of the heart.
25. The method of claim 24, wherein inserting the at least one stimulation electrode comprises inserting the electrode into the coronary sinus.
26. The method of claim 5, wherein generating and conveying the pulse comprises generating and conveying pulses at selected times of day.
27. The method of claim 5, wherein generating and conveying the pulses comprises generating and conveying pulses which increase the subject's cardiac output.
28. The method of claim 5 wherein generating and conveying the pulses comprises generating and conveying pulses which decrease the subject's cardiac output.
29. The method of claim 5, wherein generating and conveying the pulses comprises generating and conveying pulses which increase the efficiency of contraction of the heart.
30. An apparatus for modulating intracellular calcium concentration in biological tissue, comprising:
a stimulation probe, and
an electrical control unit capable of generating a non-excitatory stimulation pulse and conveying said pulse to the stimulation probe to modulate intracellular calcium concentration.
31. The apparatus of claim 30, wherein the stimulation probe comprises one or more stimulation electrodes and the pulse is conveyed to one or more of said stimulation electrodes.
32. The apparatus of claim 30, wherein the intracellular calcium concentration is increased.
33. The apparatus of claim 30, wherein the intracellular calcium concentration is decreased.
34. An apparatus for modulating intracellular calcium concentration in cardiac tissue, comprising:
a stimulation probe comprising one or more stimulation electrodes,
at least one sensor capable of generating a signal responsive to cardiac activity, and
an electrical control unit capable of generating a non-excitatory stimulation pulse responsive to the signal and conveying said pulse to at least one or the one or more stimulation electrodes to modulate intracellular calcium concentration.
35. The apparatus of claim 34, wherein the intracellular calcium concentration is increased.
36. The apparatus of claim 34, wherein the intracellular calcium concentration is decreased.
37. The apparatus of claim 34, which also comprises a sensing electrode to be introduced into the heart to sense signals and the stimulation pulse is synchronized with electrical activity sensed by the sensing electrode.
38. The apparatus of claim 34, wherein the stimulation pulse is synchronized with an ECG signal from an electrode applied to a body surface.
39. The apparatus of claim 34, wherein signals are received from at least one of the one or more stimulation electrodes.
40. The apparatus of claim 34, wherein the stimulation pulse generated has a predetermined delay relative to the signal.
41. The apparatus of claim 34, wherein the stimulation probe comprises a plurality of stimulation electrodes, and wherein the electrical control unit generates a sequence of pulses and applies each pulse in the sequence to a different one of the plurality of stimulation electrodes.
42. The apparatus of claim 34, wherein the electrical control unit generates and conveys stimulation pulses selectively, based on a characteristic of the signals received from the at least one sensor.
43. The apparatus of claim 42, wherein the electrical control unit generates and applies pulses at a rate dependent on the heart rate, but not equal to the heart rate.
44. The apparatus of claim 42, wherein the electrical control unit detects a cardiac arrhythmia and adjusts the application of the pulses responsive thereto.
45. The apparatus of claim 42, wherein the electrical control unit detects a QT interval in the signals and generates pulses responsive thereto.
46. The apparatus of claim 34, wherein in generating the non-excitatory stimulation pulse the electrical control unit varies one or more parameters of the pulse selected from the group consisting of the pulse voltage, current, duration, delay, and waveform frequency.
47. The apparatus of claim 34, wherein the pulse comprises a baseline pulse and a waveform of substantially higher frequency than the baseline pulse superimposed thereon.
48. The apparatus of claim 47, wherein the waveform comprises a square wave.
49. The apparatus of claim 34, wherein after generating and conveying the non-excitatory stimulation pulse, the electrical control unit generates and conveys another pulse of opposite polarity thereto.
50. The apparatus of claim 34, wherein the electrical control unit varies the extent of a portion of the area of the heart segment to which the non-excitatory stimulation pulse is applied.
51. The apparatus of claim 50, wherein varying the extent comprises selectively addressing a net of stimulation electrodes implanted in the heart.
52. The apparatus of claim 34, wherein the one or more stimulation electrodes as inserted into multiple chambers of the heart.
53. The apparatus of claim 34, wherein at least one of the one or more stimulation electrodes are inserted into a blood vessel of the heart.
54. The apparatus of claim 34, wherein at least one stimulation electrode is inserted into the coronary sinus.
55. The apparatus of claim 34, wherein the electrical control unit generates and conveys pulses at selected times of day.
56. The apparatus of claim 34, wherein the electrical control unit generates and conveys pulses which increase the subject's cardiac output.
57. The apparatus of claim 34, wherein the electrical control unit generates and conveys pulses which decrease the subject's cardiac output.
58. The apparatus of claim 34, wherein the electrical control unit generates and conveys pulses which increase the efficiency of contraction of the heart.
US10/116,201 1993-07-20 2002-04-03 Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue Expired - Lifetime US8825152B2 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IL116,699 1996-01-08
IL116699 1996-01-08
IL11669996A IL116699A (en) 1996-01-08 1996-01-08 Method of constructing cardiac map
US976996P true 1996-01-11 1996-01-11
US08/595,365 US5738096A (en) 1993-07-20 1996-02-01 Cardiac electromechanics
US1111796P true 1996-02-05 1996-02-05
US2639296P true 1996-09-16 1996-09-16
IL119261 1996-09-17
IL11926196A IL119261D0 (en) 1996-09-17 1996-09-17 Electrical muscle controller
IL119,261 1996-09-17
US09/101,723 US6317631B1 (en) 1996-01-08 1997-01-08 Controlling heart performance using a non-excitatory electric field
PCT/IL1997/000012 WO1997025098A1 (en) 1996-01-08 1997-01-08 Electrical muscle controller
US15751199P true 1999-10-04 1999-10-04
US09/563,544 US6363279B1 (en) 1996-01-08 2000-05-01 Electrical muscle controller
PCT/IB2000/001523 WO2001024871A2 (en) 1999-10-04 2000-10-04 Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US10/039,845 US9289618B1 (en) 1996-01-08 2001-10-23 Electrical muscle controller
US10/116,201 US8825152B2 (en) 1996-01-08 2002-04-03 Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/116,201 US8825152B2 (en) 1996-01-08 2002-04-03 Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/IB2000/001523 Continuation WO2001024871A2 (en) 1999-10-04 2000-10-04 Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US10/039,845 Continuation-In-Part US9289618B1 (en) 1996-01-08 2001-10-23 Electrical muscle controller

Publications (3)

Publication Number Publication Date
US20030040777A1 US20030040777A1 (en) 2003-02-27
US20070239216A9 true US20070239216A9 (en) 2007-10-11
US8825152B2 US8825152B2 (en) 2014-09-02

Family

ID=26813986

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/116,201 Expired - Lifetime US8825152B2 (en) 1993-07-20 2002-04-03 Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue

Country Status (1)

Country Link
US (1) US8825152B2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US8260416B2 (en) 1996-01-08 2012-09-04 Impulse Dynamics, N.V. Electrical muscle controller
US8326416B2 (en) 2003-03-10 2012-12-04 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040249421A1 (en) * 2000-09-13 2004-12-09 Impulse Dynamics Nv Blood glucose level control
US20040158289A1 (en) * 2002-11-30 2004-08-12 Girouard Steven D. Method and apparatus for cell and electrical therapy of living tissue
US7627373B2 (en) * 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US8805491B2 (en) * 2004-04-20 2014-08-12 Zoll Medical Corporation Microperfusive electrical stimulation
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
EP2094352A4 (en) 2006-12-06 2010-05-19 Cleveland Clinic Foundation Method and system for treating acute heart failure by neuromodulation
US8103343B2 (en) 2007-05-03 2012-01-24 Cardiac Pacemakers, Inc. Automatic modulation of pacing timing intervals using beat to beat measures
US9150832B2 (en) * 2007-05-08 2015-10-06 Cardiac Pacemakers, Inc. Cell training for local field stimulation
US20080280341A1 (en) * 2007-05-08 2008-11-13 Kenknight Bruce System And Method For Local Field Stimulation
US7957802B2 (en) * 2007-08-20 2011-06-07 Cardiac Pacemakers, Inc. Method, apparatus, and system to optimize cardiac preload based on measured pulmonary artery pressure
US7904156B2 (en) * 2007-08-20 2011-03-08 Cardiac Pacemakers, Inc. Modulation of AV delay to control ventricular interval variability
WO2010033190A2 (en) 2008-09-16 2010-03-25 Cardiac Pacemakers, Inc. Cardiac function management integrating cardiac contractility modulation
CA3015372A1 (en) 2016-03-09 2017-09-14 CARDIONOMIC, Inc. Cardiac contractility neurostimulation systems and methods

Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4947A (en) * 1847-02-01 Apparatus for closing doors
US3572345A (en) * 1965-10-13 1971-03-23 Philips Corp Strap for a heart stimulator
US3651806A (en) * 1969-10-24 1972-03-28 Philip I Hirshberg Method and apparatus for administering digitalizing medications
US3651805A (en) * 1969-05-12 1972-03-28 Draegerwerk Ag Anesthetic vaporizer
US3796221A (en) * 1971-07-07 1974-03-12 N Hagfors Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means
US3933147A (en) * 1970-04-02 1976-01-20 Vall Wilbur E Du Apparatus and method for treating disorders in the region of the pubococcygeous muscle
US3942536A (en) * 1971-03-15 1976-03-09 Mieczyslaw Mirowski Cardioverting device having single intravascular catheter electrode system and method for its use
US3944740A (en) * 1973-07-31 1976-03-16 Fujitsu Limited Coordinate position information output device
US4184493A (en) * 1975-09-30 1980-01-22 Mieczyslaw Mirowski Circuit for monitoring a heart and for effecting cardioversion of a needy heart
US4312354A (en) * 1980-02-04 1982-01-26 Arco Medical Products Company Pacemaker with circuit for pulse width modulating stimulus pulses in accordance with programmed parameter control states
US4315503A (en) * 1976-11-17 1982-02-16 Electro-Biology, Inc. Modification of the growth, repair and maintenance behavior of living tissues and cells by a specific and selective change in electrical environment
US4369791A (en) * 1979-10-01 1983-01-25 Medtronic, Inc. Body implantable electrode
US4428366A (en) * 1981-05-06 1984-01-31 Alfred B. Kurtz Electromagnetic apparatus and method for the reduction of serum glucose levels
US4506608A (en) * 1983-01-07 1985-03-26 Electrodyne Research Corp. Unfired drying and sorting apparatus for preparation of solid fuel and other solid material
US4566456A (en) * 1984-10-18 1986-01-28 Cordis Corporation Apparatus and method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output
US4572191A (en) * 1974-04-25 1986-02-25 Mieczyslaw Mirowski Command atrial cardioverter
US4637397A (en) * 1985-05-30 1987-01-20 Case Western Reserve University Triphasic wave defibrillation
US4639720A (en) * 1981-01-12 1987-01-27 Harris Corporation Electronic sketch pad
US4651716A (en) * 1982-12-03 1987-03-24 Canadian Patents And Development Limited Method and device for enhancement of cardiac contractility
US4717581A (en) * 1986-02-06 1988-01-05 Eic Laboratories, Inc. Iridium oxide coated electrodes for neural stimulation
US4726279A (en) * 1986-11-12 1988-02-23 United Technologies Corporation Wake stabilized supersonic combustion ram cannon
US4726379A (en) * 1985-11-14 1988-02-23 Cardiac Control Systems, Inc. Cardiac pacer with switching circuit for isolation
US4988837A (en) * 1987-12-25 1991-01-29 Wacom Co., Ltd. Position detecting device
US4996984A (en) * 1989-09-26 1991-03-05 Eli Lilly And Company Defibrillation method
US4998531A (en) * 1990-03-28 1991-03-12 Cardiac Pacemakers, Inc. Implantable N-phasic defibrillator output bridge circuit
US4998532A (en) * 1986-05-23 1991-03-12 Lti Biomedical, Inc. Portable electro-therapy system
US5002052A (en) * 1988-08-29 1991-03-26 Intermedics, Inc. System and method for detection and treatment of ventricular arrhythmias
US5083564A (en) * 1990-06-01 1992-01-28 Board Of Regents Of The University Of Oklahoma Method for alleviating and diagnosing symptoms of heart block
US5085218A (en) * 1990-08-31 1992-02-04 Cardiac Pacemakers, Inc. Bipolar myocardial positive fixation lead with improved sensing capability
US5087243A (en) * 1990-06-18 1992-02-11 Boaz Avitall Myocardial iontophoresis
US5097833A (en) * 1989-09-19 1992-03-24 Campos James M Transcutaneous electrical nerve and/or muscle stimulator
US5097832A (en) * 1990-03-09 1992-03-24 Siemens-Pacesetter, Inc. System and method for preventing false pacemaker pvc response
US5097843A (en) * 1990-04-10 1992-03-24 Siemens-Pacesetter, Inc. Porous electrode for a pacemaker
US5184620A (en) * 1991-12-26 1993-02-09 Marquette Electronics, Inc. Method of using a multiple electrode pad assembly
US5184616A (en) * 1991-10-21 1993-02-09 Telectronics Pacing Systems, Inc. Apparatus and method for generation of varying waveforms in arrhythmia control system
US5185620A (en) * 1991-08-22 1993-02-09 Cooper George F Eyeglass system
US5188104A (en) * 1991-02-01 1993-02-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5281219A (en) * 1990-11-23 1994-01-25 Medtronic, Inc. Multiple stimulation electrodes
US5284491A (en) * 1992-02-27 1994-02-08 Medtronic, Inc. Cardiac pacemaker with hysteresis behavior
US5286254A (en) * 1990-06-15 1994-02-15 Cortrak Medical, Inc. Drug delivery apparatus and method
US5292344A (en) * 1992-07-10 1994-03-08 Douglas Donald D Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port
US5381160A (en) * 1991-09-27 1995-01-10 Calcomp Inc. See-through digitizer with clear conductive grid
US5386837A (en) * 1993-02-01 1995-02-07 Mmtc, Inc. Method for enhancing delivery of chemotherapy employing high-frequency force fields
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
US5386835A (en) * 1990-03-30 1995-02-07 Elphick; Kevin J. Barrier means
US5391199A (en) * 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US5391192A (en) * 1994-03-04 1995-02-21 Telectronics Pacing Systems, Inc. Automatic ventricular pacing pulse threshold determination utilizing an external programmer and a surface electrocardiogram
US5397344A (en) * 1992-12-22 1995-03-14 Schering Aktiengesellschaft Methods of and apparatus for measuring uterine electrical and mechanical activity
US5398683A (en) * 1991-05-24 1995-03-21 Ep Technologies, Inc. Combination monophasic action potential/ablation catheter and high-performance filter system
US5402151A (en) * 1989-10-02 1995-03-28 U.S. Philips Corporation Data processing system with a touch screen and a digitizing tablet, both integrated in an input device
US5482052A (en) * 1991-04-29 1996-01-09 Lerner; Eduard N. Method and apparatus for determining sensory functions
US5489293A (en) * 1993-08-31 1996-02-06 Ventritex, Inc. Method and apparatus for treating cardiac tachyarrhythmia
US5495077A (en) * 1992-06-08 1996-02-27 Synaptics, Inc. Object position and proximity detector
US5499971A (en) * 1990-06-15 1996-03-19 Cortrak Medical, Inc. Method for iontophoretically delivering drug adjacent to a heart
US5501662A (en) * 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5601609A (en) * 1993-09-15 1997-02-11 Pacesetter, Inc. Implantable cardiac stimulating device and method for administering synchronized cardioversion shock therapy to provide preemptive depolarization
US5601611A (en) * 1994-08-05 1997-02-11 Ventritex, Inc. Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same
US5713929A (en) * 1996-05-03 1998-02-03 Medtronic, Inc. Arrhythmia and fibrillation prevention pacemaker using ratchet up and decay modes of operation
US5713924A (en) * 1995-06-27 1998-02-03 Medtronic, Inc. Defibrillation threshold reduction system
US5713935A (en) * 1996-08-23 1998-02-03 Sulzer Intermedics Inc. Method and apparatus for monitored biphasic cardiac impedance sensing
US5720768A (en) * 1996-05-22 1998-02-24 Sulzer Intermedics Inc. Dual chamber pacing with interchamber delay
US5861583A (en) * 1992-06-08 1999-01-19 Synaptics, Incorporated Object position detector
US5861014A (en) * 1997-04-30 1999-01-19 Medtronic, Inc. Method and apparatus for sensing a stimulating gastrointestinal tract on-demand
US5865787A (en) * 1992-10-06 1999-02-02 Cortrak Medical, Inc. Simultaneous cardiac pacing and local drug delivery
US5871506A (en) * 1996-08-19 1999-02-16 Mower; Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US6023640A (en) * 1999-03-29 2000-02-08 Ross; Jesse Method contributing to obviating male impotency
US6026326A (en) * 1997-01-13 2000-02-15 Medtronic, Inc. Apparatus and method for treating chronic constipation
US6032074A (en) * 1995-10-11 2000-02-29 Trustees Of Boston University Method and apparatus for improving the function of sensory cells
US6032672A (en) * 1996-02-20 2000-03-07 Cardiothoracic Systems, Inc. Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery
US6037882A (en) * 1997-09-30 2000-03-14 Levy; David H. Method and apparatus for inputting data to an electronic system
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US6178351B1 (en) * 1996-08-19 2001-01-23 The Mower Family Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US6337995B1 (en) * 1996-08-19 2002-01-08 Mower Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention for atrial fibrillation
US6341235B1 (en) * 1996-08-19 2002-01-22 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US20020010492A1 (en) * 2000-03-06 2002-01-24 Medtronic, Inc. Subthreshold stimulator for angiogenesis
US6343232B1 (en) * 1966-08-19 2002-01-29 Mower Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US20020026141A1 (en) * 1999-11-04 2002-02-28 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6363279B1 (en) * 1996-01-08 2002-03-26 Impulse Dynamics N.V. Electrical muscle controller
US6504530B1 (en) * 1999-09-07 2003-01-07 Elo Touchsystems, Inc. Touch confirming touchscreen utilizing plural touch sensors
US6507093B2 (en) * 2000-04-19 2003-01-14 Nec Corporation Lead frame for fabricating surface mount type semiconductor devices with high reliability
US6505745B1 (en) * 2000-08-01 2003-01-14 Richard E Anderson Holder for articles such as napkins
US20030018367A1 (en) * 2001-07-23 2003-01-23 Dilorenzo Daniel John Method and apparatus for neuromodulation and phsyiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20030028221A1 (en) * 2001-07-31 2003-02-06 Qingsheng Zhu Cardiac rhythm management system for edema
US6684104B2 (en) * 1999-04-14 2004-01-27 Transneuronix, Inc. Gastric stimulator apparatus and method for installing
US6690156B1 (en) * 2000-07-28 2004-02-10 N-Trig Ltd. Physical object location apparatus and method and a graphic display device using the same
US20050021101A1 (en) * 2000-04-11 2005-01-27 Jiande Chen Gastrointestinal electrical stimulation
US6853862B1 (en) * 1999-12-03 2005-02-08 Medtronic, Inc. Gastroelectric stimulation for influencing pancreatic secretions
US20050033396A1 (en) * 2003-04-10 2005-02-10 Peter Ospyka Cardiac electrode anchoring system
US20060036126A1 (en) * 2004-08-16 2006-02-16 Jeffrey Ross Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US7006871B1 (en) * 1997-07-16 2006-02-28 Metacure N.V. Blood glucose level control
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US7167748B2 (en) * 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US7171263B2 (en) * 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US20070027487A1 (en) * 2003-03-10 2007-02-01 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US20070027490A1 (en) * 1996-09-16 2007-02-01 Shlomo Ben-Haim Fencing of Cardiac Muscles
US20100016923A1 (en) * 2004-03-10 2010-01-21 Impulse Dynamics Nv Protein activity modification
US20100035963A1 (en) * 2005-09-09 2010-02-11 Ayelet Chajut Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease
US20130009639A1 (en) * 2011-06-13 2013-01-10 Toshiba Medical Systems Corporation Magnetic resonance imaging apparatus and load calculation method of a gradient magnetic field generation system

Family Cites Families (334)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB304587A (en) 1928-01-21 1930-03-13 Abraham Esau Improvements in apparatus for treatment by diathermy
US3211154A (en) 1962-06-25 1965-10-12 Mine Safety Appliances Co Sequence switch for ventricular defibrillator
DE1679493B1 (en) 1967-05-02 1970-06-04 Berckheim Graf Von Arrangement for electric air conditioning of rooms in buildings and vehicles
US3587567A (en) 1968-12-20 1971-06-28 Peter Paul Schiff Mechanical ventricular assistance assembly
GB1394171A (en) 1973-05-16 1975-05-14 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US3911930A (en) 1974-03-01 1975-10-14 Stimulation Tech Method and structure of preventing and treating ileus, and reducing acute pain by electrical pulse stimulation
US4316472C1 (en) 1974-04-25 2001-08-14 Mieczyslaw Mirowski Cardioverting device with stored energy selecting means and discharge initiating means and related method
US3952750A (en) 1974-04-25 1976-04-27 Mieczyslaw Mirowski Command atrial cardioverting device
US3924641A (en) 1974-08-19 1975-12-09 Axotronics Inc Bi-phasic current stimulation system
US4055190A (en) 1974-12-19 1977-10-25 Michio Tany Electrical therapeutic apparatus
US4030509A (en) 1975-09-30 1977-06-21 Mieczyslaw Mirowski Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization
US4202340A (en) 1975-09-30 1980-05-13 Mieczyslaw Mirowski Method and apparatus for monitoring heart activity, detecting abnormalities, and cardioverting a malfunctioning heart
US4106494A (en) 1977-08-29 1978-08-15 American Optical Corporation Heart defibrillating and monitoring system
US4164216A (en) 1978-01-26 1979-08-14 Person Orville W Throat obstruction expulsion device
US4223678A (en) 1978-05-03 1980-09-23 Mieczyslaw Mirowski Arrhythmia recorder for use with an implantable defibrillator
US4168711A (en) 1978-06-08 1979-09-25 American Optical Corporation Reversal protection for RLC defibrillator
US4273114A (en) 1978-10-19 1981-06-16 Michigan Instruments, Inc. Cardiopulmonary resuscitator, defibrillator and monitor
US4293734A (en) 1979-02-23 1981-10-06 Peptek, Incorporated Touch panel system and method
US4237895A (en) 1979-04-20 1980-12-09 Medcor, Inc. Control signal transmitter and monitor for implanted pacer
US4403614A (en) 1979-07-19 1983-09-13 Medtronic, Inc. Implantable cardioverter
US4337776A (en) 1980-08-29 1982-07-06 Telectronics Pty. Ltd. Impedance measuring pacer
US4440172A (en) 1980-10-02 1984-04-03 Mieczyslaw Mirowski Apparatus for combining pacing and cardioverting functions in a single implanted device
US4387717A (en) 1980-10-03 1983-06-14 Research Corporation Pacer internal cardiac electrogram sensing system
JPS6334732B2 (en) 1980-10-21 1988-07-12 Tokyo Shibaura Electric Co
US4537195A (en) 1980-11-20 1985-08-27 Mcdonnell Roy E Electrical control of body discharges and headaches
US4407288B1 (en) 1981-02-18 2000-09-19 Mieczyslaw Mirowski Implantable heart stimulator and stimulation method
US4384585A (en) 1981-03-06 1983-05-24 Medtronic, Inc. Synchronous intracardiac cardioverter
US4693253A (en) 1981-03-23 1987-09-15 Medtronic, Inc. Automatic implantable defibrillator and pacer
US4406288A (en) 1981-04-06 1983-09-27 Hugh P. Cash Bladder control device and method
US4765341A (en) 1981-06-22 1988-08-23 Mieczyslaw Mirowski Cardiac electrode with attachment fin
US4411268A (en) 1982-02-10 1983-10-25 Medtronic, Inc. Muscle stimulator
US4543738A (en) 1982-03-30 1985-10-01 Mower Morton M Ski boot for concentrating a skier's weight on a ski edge
US4708145A (en) 1982-06-01 1987-11-24 Medtronic, Inc. Sequential-pulse, multiple pathway defibrillation method
US4559946A (en) 1982-06-18 1985-12-24 Mieczyslaw Mirowski Method and apparatus for correcting abnormal cardiac activity by low energy shocks
US4554922A (en) 1982-09-30 1985-11-26 Prystowsky Eric N Method of inhibiting cardiac arrhythmias
US4506680A (en) 1983-03-17 1985-03-26 Medtronic, Inc. Drug dispensing body implantable lead
CA1247960A (en) 1983-03-24 1989-01-03 Hideki Aoki Transcutaneously implantable element
US4554992A (en) 1983-09-09 1985-11-26 Fmc Corporation Hydraulically operated four wheel sweeper
US4550221A (en) 1983-10-07 1985-10-29 Scott Mabusth Touch sensitive control device
US4559947A (en) 1984-01-27 1985-12-24 Renger Herman L Cardiac tissue stimulator providing P-wave verification, telemetry, marker channels, and antitachycardia capabilities
EP0156593A3 (en) 1984-03-22 1985-12-27 AMP INCORPORATED (a New Jersey corporation) Method and apparatus for mode changes and/or touch mouse control
US4543956A (en) 1984-05-24 1985-10-01 Cordis Corporation Biphasic cardiac pacer
US4628934A (en) 1984-08-07 1986-12-16 Cordis Corporation Method and means of electrode selection for pacemaker with multielectrode leads
US4674508A (en) 1985-05-28 1987-06-23 Cordis Corporation Low-power consumption cardiac pacer based on automatic verification of evoked contractions
US4690155A (en) 1985-07-03 1987-09-01 Cordis Corporation Monophasic action potential recording lead
GB8526417D0 (en) 1985-10-25 1985-11-27 Davies D W Recognition of ventricular tachycardia
US4679572A (en) 1986-03-11 1987-07-14 Intermedics, Inc. Low threshold cardiac pacing electrodes
US4834100A (en) 1986-05-12 1989-05-30 Charms Bernard L Apparatus and method of defibrillation
EP0247296B1 (en) 1986-05-22 1991-08-28 Siemens Aktiengesellschaft Cardiac measuring device for determining the oxygen saturation in blood
US4830006B1 (en) 1986-06-17 1997-10-28 Intermedics Inc Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias
US4686332A (en) 1986-06-26 1987-08-11 International Business Machines Corporation Combined finger touch and stylus detection system for use on the viewing surface of a visual display device
JPH0253805B2 (en) 1986-09-12 1990-11-19 Wakomu Kk
DE3732640C1 (en) 1987-09-28 1989-05-18 Alt Eckhard Medical Geraet for detecting physiological function parameters
US4870974A (en) 1987-09-30 1989-10-03 Chinese Pla General Hospital Apparatus and method for detecting heart characteristics by way of electrical stimulation
US4967749A (en) 1987-10-06 1990-11-06 Leonard Bloom Hemodynamically responsive system for and method of treating a malfunctioning heart
US5018522A (en) 1987-10-26 1991-05-28 Medtronic, Inc. Ramped waveform non-invasive pacemaker
US5067940A (en) 1988-03-23 1991-11-26 Life Resonances, Inc. Method and apparatus for controlling the growth of cartilage
US5144554A (en) 1989-03-04 1992-09-01 Xueshan Zhang Apparatus for diagnosing and providing therapy for gastrointestinal diseases without causing patient discomfort and injury
US4914624A (en) 1988-05-06 1990-04-03 Dunthorn David I Virtual button for touch screen
DE3816042A1 (en) 1988-05-10 1989-11-23 Alt Eckhard Energy-saving pacemaker
CA1327838C (en) 1988-06-13 1994-03-15 Fred Zacouto Implantable device to prevent blood clotting disorders
US4850959A (en) 1988-08-02 1989-07-25 Bioresearch, Inc. Bioelectrochemical modulation of biological functions using resonant/non-resonant fields synergistically
JPH0538723Y2 (en) 1988-12-19 1993-09-30
US4928688A (en) 1989-01-23 1990-05-29 Mieczyslaw Mirowski Method and apparatus for treating hemodynamic disfunction
USRE38119E1 (en) 1989-01-23 2003-05-20 Mirowski Family Ventures, LLC Method and apparatus for treating hemodynamic disfunction
US5031617A (en) 1989-03-13 1991-07-16 Klettner Harold L Method of altering human blood glucose levels by the application of electric charge
US5433730A (en) 1989-05-03 1995-07-18 Intermedics, Inc. Conductive pouch electrode for defibrillation
US5048522A (en) 1990-04-13 1991-09-17 Therapeutic Technologies, Inc. Power muscle stimulator
US4971058A (en) 1989-07-06 1990-11-20 Ventritex, Inc. Cardiac therapy method with duration timer
US5101814A (en) 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5063929A (en) 1989-08-25 1991-11-12 Staodyn, Inc. Electronic stimulating device having timed treatment of varying intensity and method therefor
US5050612A (en) 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
EP0421025B1 (en) 1989-10-02 1999-05-06 Philips Electronics N.V. Data processing system with a touch screen and a digitizing tablet, both integrated in an input device
US5041107A (en) 1989-10-06 1991-08-20 Cardiac Pacemakers, Inc. Electrically controllable, non-occluding, body implantable drug delivery system
US5020544A (en) 1989-11-01 1991-06-04 Cardiac Pacemakers, Inc. Low energy defibrillation electrode
US5044375A (en) 1989-12-08 1991-09-03 Cardiac Pacemakers, Inc. Unitary intravascular defibrillating catheter with separate bipolar sensing
US5236413B1 (en) 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5320642A (en) 1990-06-01 1994-06-14 Board Of Regents For The University Of Ok Method for alleviating and diagnosing symptoms of heart block
US5205284A (en) 1990-06-12 1993-04-27 Zoll Medical Corporation Method and apparatus for transcutaneous electrical cardiac pacing with background stimulation
US5431688A (en) 1990-06-12 1995-07-11 Zmd Corporation Method and apparatus for transcutaneous electrical cardiac pacing
US5458568A (en) 1991-05-24 1995-10-17 Cortrak Medical, Inc. Porous balloon for selective dilatation and drug delivery
US5111814A (en) 1990-07-06 1992-05-12 Thomas Jefferson University Laryngeal pacemaker
US5233985A (en) 1990-08-10 1993-08-10 Medtronic, Inc. Cardiac pacemaker with operational amplifier output circuit
US5370665A (en) 1990-08-10 1994-12-06 Medtronic, Inc. Medical stimulator with multiple operational amplifier output stimulation circuits
US5156149A (en) 1990-08-10 1992-10-20 Medtronic, Inc. Sensor for detecting cardiac depolarizations particularly adapted for use in a cardiac pacemaker
US5267560A (en) 1990-09-07 1993-12-07 Cohen Fred M Methods for control of the ventricular activation sequence
US5584804A (en) 1990-10-10 1996-12-17 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5163428A (en) 1990-10-11 1992-11-17 Ventritex, Inc. Implantable cardiac defibrillator with current leakage detecting means
US5111815A (en) 1990-10-15 1992-05-12 Cardiac Pacemakers, Inc. Method and apparatus for cardioverter/pacer utilizing neurosensing
EP0481684A3 (en) 1990-10-19 1993-03-03 Angelase, Inc. Location and ablation of an active site of ventricular tachycardia
US5154501A (en) 1990-10-19 1992-10-13 Angelase, Inc. Process for identification of an active site of ventricular tachycardia and for electrode attachment of an endocardial defibrilator
US5172699A (en) 1990-10-19 1992-12-22 Angelase, Inc. Process of identification of a ventricular tachycardia (VT) active site and an ablation catheter system
US5172690A (en) 1990-10-26 1992-12-22 Telectronics Pacing Systems, Inc. Automatic stimulus artifact reduction for accurate analysis of the heart's stimulated response
US5133354A (en) 1990-11-08 1992-07-28 Medtronic, Inc. Method and apparatus for improving muscle tone
US5163427A (en) 1990-11-14 1992-11-17 Medtronic, Inc. Apparatus for delivering single and multiple cardioversion and defibrillation pulses
US5137021A (en) 1990-11-29 1992-08-11 Medtronic, Inc. Lead current measurement circuit
US5174286A (en) 1990-12-07 1992-12-29 Raul Chirife Sensor for right ventricular and thoracic volumes using the trailing edge value of a generated pulse
US5129394A (en) 1991-01-07 1992-07-14 Medtronic, Inc. Method and apparatus for controlling heart rate in proportion to left ventricular pressure
US5476497A (en) 1991-01-09 1995-12-19 Ann Mirowski Oval electrode lead body
IT1246631B (en) 1991-01-25 1994-11-24 Gd Spa Conveyor of stabilization of cigarette packets out of a packing machine.
US5107834A (en) 1991-01-30 1992-04-28 Cardiac Pacemakers, Inc. Low energy multiple shock defibrillation/cardioversion discharge technique and electrode configuration
US5156147A (en) 1991-02-05 1992-10-20 Cardiac Pacemakers, Inc. Variable rate pacemaker having upper rate limit governor based on hemodynamic performance
US5161527A (en) 1991-02-13 1992-11-10 Telectronics Pacing Systems, Inc. Apparatus and method for detecting abnormal cardiac rhythms in dual chamber arrhythmia control system
US5190036A (en) 1991-02-28 1993-03-02 Linder Steven H Abdominal binder for effectuating cough stimulation
US5188106A (en) 1991-03-08 1993-02-23 Telectronics Pacing Systems, Inc. Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound
US5697953A (en) 1993-03-13 1997-12-16 Angeion Corporation Implantable cardioverter defibrillator having a smaller displacement volume
US5199428A (en) 1991-03-22 1993-04-06 Medtronic, Inc. Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload
US5464020A (en) 1991-03-25 1995-11-07 Lerner; Albert M. Diagnosing and treating subacute cardiac dysfunction
US5584803A (en) 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5213098A (en) 1991-07-26 1993-05-25 Medtronic, Inc. Post-extrasystolic potentiation stimulation with physiologic sensor feedback
US5231988A (en) 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5230336A (en) 1991-08-16 1993-07-27 Ventritex, Inc. Method and apparatus for impedance based automatic pulse duration adjustment for defibrillation shock delivery
US5314448A (en) 1991-10-28 1994-05-24 Angeion Corporation Process for defibrillation pretreatment of a heart
US5522853A (en) 1992-10-27 1996-06-04 Angeion Corporation Method and apparatus for progressive recruitment of cardiac fibrillation
DE69213657T2 (en) 1991-11-04 1997-01-23 Cardiac Pacemakers Inc An implantable device for monitoring and stimulation of the heart for diagnosis and therapy
US5324327A (en) 1991-12-17 1994-06-28 Cohen Donald M Low threshold cardiac pacing lead
FR2685624B1 (en) 1991-12-31 1994-03-11 Ela Medical System analysis of cardiac activity for implantable device for treating tachycardias.
US5534015A (en) 1992-02-18 1996-07-09 Angeion Corporation Method and apparatus for generating biphasic waveforms in an implantable defibrillator
US5531764A (en) 1992-03-24 1996-07-02 Angeion Corporation Implantable defibrillator system and method having successive changeable defibrillation waveforms
US5342404A (en) 1992-04-03 1994-08-30 Intermedics, Inc. Implantable medical interventional device
US5365461A (en) 1992-04-30 1994-11-15 Microtouch Systems, Inc. Position sensing computer input device
RU2014844C1 (en) 1992-05-06 1994-06-30 Московский областной научно-исследовательский клинический институт Method for treating viral diarrhea
US5350403A (en) 1992-06-17 1994-09-27 Siemens Aktiengesellschaft Apparatus for charging living tissue with electrical pulses
IT1260485B (en) 1992-05-29 1996-04-09 Method and device for the treatment of obesity 'of a patient
US5543588A (en) 1992-06-08 1996-08-06 Synaptics, Incorporated Touch pad driven handheld computing device
US6239389B1 (en) 1992-06-08 2001-05-29 Synaptics, Inc. Object position detection system and method
US5914465A (en) 1992-06-08 1999-06-22 Synaptics, Inc. Object position detector
RU2055606C1 (en) 1992-06-15 1996-03-10 Научно-исследовательский институт полупроводниковых приборов Electric stimulator for stomach-guts section
US5366486A (en) 1992-06-25 1994-11-22 Indiana University Foundation Automatic fibrillation detector and defibrillator apparatus and method
US5243980A (en) 1992-06-30 1993-09-14 Medtronic, Inc. Method and apparatus for discrimination of ventricular and supraventricular tachycardia
US5342401A (en) 1992-08-19 1994-08-30 The Regents Of The University Of California Real time cardiac arrhythmia stabilizing system
SE9202663D0 (en) 1992-09-16 1992-09-16 Siemens Elema Ab implantable hjaertdefibrillator
SE9202662D0 (en) 1992-09-16 1992-09-16 Siemens Elema Ab Device Foer producing of stimulation pulses and defibrillation shocks formed hjaertdefibrilleringssekvenser
US5662687A (en) 1992-09-16 1997-09-02 Pacesetter Ab Implantable heart defibrillator
US5320643A (en) 1992-10-06 1994-06-14 Medtronic, Inc. Automatic cardiac capture restoration and threshold-seeking method and apparatus
WO1994008657A1 (en) 1992-10-20 1994-04-28 Noel Desmond Gray A heart pacemaker
US5334222A (en) 1992-11-03 1994-08-02 Cardiac Pacemakers, Inc. Cardiac stimulating apparatus and method for heart failure therapy
SE9203284D0 (en) 1992-11-04 1992-11-04 Siemens Elema Ab Hjaertstimulator
US5807306A (en) 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
US5346506A (en) 1992-11-10 1994-09-13 Mower Morton M Method for establishing defibrillation threshold for a cardiac defibrillator
US5318591A (en) 1992-11-23 1994-06-07 Siemens Pacesetter, Inc. Implantable cardioverter-defibrillator having early charging capability
US5353800A (en) 1992-12-11 1994-10-11 Medtronic, Inc. Implantable pressure sensor lead
US5991649A (en) 1992-12-22 1999-11-23 University Of Texas Methods for activating the muscle cells or nerves of the uterus or cervix
US5447526A (en) 1992-12-24 1995-09-05 Karsdon; Jeffrey Transcutaneous electric muscle/nerve controller/feedback unit
US5327887A (en) 1993-01-25 1994-07-12 Ludwik Nowakowski Cardiopulmonary resuscitation device
US5320543A (en) 1993-02-04 1994-06-14 Barton Craig S Flexible plug protector
US6133906A (en) 1993-03-15 2000-10-17 Microtouch Systems, Inc. Display-integrated stylus detection system
JP2986047B2 (en) 1993-04-29 1999-12-06 インターナショナル・ビジネス・マシーンズ・コーポレイション Display device and an input processing device and method for digital input
US5445609A (en) 1993-05-28 1995-08-29 Alza Corporation Electrotransport agent delivery device having a disposable component and a removable liner
US5528002A (en) 1993-07-15 1996-06-18 Pentel Kabushiki Kaisha Noiseproof digitizing apparatus with low power cordless pen
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
IL125136A (en) 1996-01-08 2003-07-31 Impulse Dynamics Nv Electrical cardiac muscle controller method and apparatus
US5738096A (en) 1993-07-20 1998-04-14 Biosense, Inc. Cardiac electromechanics
US5468254A (en) 1993-07-26 1995-11-21 Cardiac Pacemakers, Inc. Method and apparatus for defibrillation using a multiphasic truncated exponential waveform
US5571997A (en) 1993-08-02 1996-11-05 Kurta Corporation Pressure sensitive pointing device for transmitting signals to a tablet
US5368040A (en) 1993-08-02 1994-11-29 Medtronic, Inc. Apparatus and method for determining a plurality of hemodynamic variables from a single, chroniclaly implanted absolute pressure sensor
BE1007462A3 (en) 1993-08-26 1995-07-04 Philips Electronics Nv Data processing device with touch sensor and power.
US5443485A (en) 1993-09-08 1995-08-22 Intermedics, Inc. Apparatus and method for capture detection in a cardiac stimulator
US5447525A (en) 1993-09-15 1995-09-05 Medtronic, Inc. Pacemaker which adapts to minimize current drain and provide desired capture safety margin
US5415629A (en) 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
US5476485A (en) 1993-09-21 1995-12-19 Pacesetter, Inc. Automatic implantable pulse generator
US5411531A (en) 1993-09-23 1995-05-02 Medtronic, Inc. Method and apparatus for control of A-V interval
SE9303736D0 (en) 1993-11-12 1993-11-12 Siemens Elema Ab Device designed to detect the physical condition of a living being
GB9302462D0 (en) 1993-12-01 1993-03-24 Semple Keith Motor cycle centre-stand lock
US5431693A (en) 1993-12-10 1995-07-11 Intermedics, Inc. Method of verifying capture of the heart by a pacemaker
US5425363A (en) 1993-12-17 1995-06-20 Wang; Yong G. Plunge electrode for recording multiple intramyocardial monophasic action potential
US5419763B1 (en) 1994-01-04 1997-07-15 Cor Trak Medical Inc Prostatic drug-delivery catheter
RU2077273C1 (en) 1994-02-08 1997-04-20 Вениамин Иванович Шапошников Method to apply intestinal and gastric fistulas
EP0672427A1 (en) 1994-03-17 1995-09-20 Siemens Elema AB System for infusion of medicine into the body of a patient
IT233201Y1 (en) 1994-03-24 2000-01-26 Bracco Spa A device in two components for the administration of drugs
GB9406702D0 (en) 1994-04-05 1994-05-25 Binstead Ronald P Multiple input proximity detector and touchpad system
WO1995028988A1 (en) 1994-04-21 1995-11-02 Medtronic, Inc. Treatment of atrial fibrillation
US5562708A (en) 1994-04-21 1996-10-08 Medtronic, Inc. Method and apparatus for treatment of atrial fibrillation
KR100300397B1 (en) 1994-04-21 2001-06-16 김순택 System having touch panel and digitizer function and driving method
US5540722A (en) 1994-05-16 1996-07-30 Physiometrix, Inc. Switch apparatus and method for switching between multiple electrodes for diagnostic and therapeutic procedures
US5527345A (en) 1994-05-17 1996-06-18 Infinger; Kenneth R. Implantable atrial defibrillator having an intermittenly activated pacing modality
US5543589A (en) 1994-05-23 1996-08-06 International Business Machines Corporation Touchpad with dual sensor that simplifies scanning
JP3186946B2 (en) 1994-05-31 2001-07-11 シャープ株式会社 Coordinate detecting device
US5735876A (en) 1994-05-31 1998-04-07 Galvani Ltd. Electrical cardiac output forcing method and apparatus for an atrial defibrillator
JP2691510B2 (en) 1994-06-02 1997-12-17 株式会社バイオセンサー研究所 Measuring device of the enzyme
US5514162A (en) 1994-06-07 1996-05-07 Pacesetter, Inc. System and method for automatically determining the slope of a transfer function for a rate-responsive cardiac pacemaker
US5505700A (en) 1994-06-14 1996-04-09 Cordis Corporation Electro-osmotic infusion catheter
US5681278A (en) 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
EP0688579B1 (en) 1994-06-24 2001-08-22 St. Jude Medical AB Device for heart therapy
US5771890A (en) 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
SE9402865D0 (en) 1994-08-29 1994-08-29 Siemens Elema Ab The implantable cardiac defibrillator
US5626622A (en) 1994-09-21 1997-05-06 Telectronics Pacing Systems, Inc. Dual sensor rate responsive pacemaker
US5540734A (en) 1994-09-28 1996-07-30 Zabara; Jacob Cranial nerve stimulation treatments using neurocybernetic prosthesis
US5687734A (en) 1994-10-20 1997-11-18 Hewlett-Packard Company Flexible patient monitoring system featuring a multiport transmitter
DE4440386A1 (en) 1994-11-11 1996-05-15 Pacesetter Ab Electrodes for medical applications
US5736580A (en) 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5622687A (en) 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
TW274598B (en) 1994-11-15 1996-04-21 Alps Electric Co Ltd Coordinate input device for pen of finger tip
US5549646A (en) 1994-12-06 1996-08-27 Pacesetter, Inc. Periodic electrical lead intergrity testing system and method for implantable cardiac stimulating devices
US5476487A (en) 1994-12-28 1995-12-19 Pacesetter, Inc. Autothreshold assessment in an implantable pacemaker
US5654030A (en) 1995-02-07 1997-08-05 Intermedics, Inc. Method of making implantable stimulation electrodes
SE9500620D0 (en) 1995-02-20 1995-02-20 Pacesetter Ab Device for cardiac stimulation
JPH08227336A (en) 1995-02-20 1996-09-03 Wacom Co Ltd Pressure sensing mechanism and stylus pen
US5626620A (en) 1995-02-21 1997-05-06 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5556421A (en) 1995-02-22 1996-09-17 Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
DE69623706T2 (en) 1995-02-22 2003-05-22 Koninkl Philips Electronics Nv Low cost resistant tray with contact and stylus functionality
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US5790107A (en) 1995-06-07 1998-08-04 Logitech, Inc. Touch sensing method and apparatus
US5995860A (en) 1995-07-06 1999-11-30 Thomas Jefferson University Implantable sensor and system for measurement and control of blood constituent levels
US5956020A (en) 1995-07-27 1999-09-21 Microtouch Systems, Inc. Touchscreen controller with pen and/or finger inputs
US5836311A (en) 1995-09-20 1998-11-17 Medtronic, Inc. Method and apparatus for temporarily immobilizing a local area of tissue
JP3171373B2 (en) 1995-10-12 2001-05-28 アルプス電気株式会社 Small current detector circuit and a coordinate input apparatus using the same
US5738105A (en) 1995-10-24 1998-04-14 Angeion Corporation Method and apparatus for sensing R-waves using both near field and far field sensing simultaneously
US5741211A (en) 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US6473069B1 (en) 1995-11-13 2002-10-29 Cirque Corporation Apparatus and method for tactile feedback from input device
RU2078547C1 (en) 1995-11-28 1997-05-10 Центральный научно-исследовательский рентгено-радиологический институт МЗМП РФ Method for treating polyposis of stomach and duodenum
US5779661A (en) 1995-12-11 1998-07-14 Physion, S.R.L. Method of treating dysfunctional bladder syndromes by electromotive drug administration
JP3048067B2 (en) 1995-12-15 2000-06-05 ノボ ノルディスク アクティーゼルスカブ New method
US5825352A (en) 1996-01-04 1998-10-20 Logitech, Inc. Multiple fingers contact sensing method for emulating mouse buttons and mouse operations on a touch sensor pad
US5920309A (en) 1996-01-04 1999-07-06 Logitech, Inc. Touch sensing method and apparatus
JP4175662B2 (en) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ.ヴイ. Electrical muscle control device
JPH09190268A (en) 1996-01-11 1997-07-22 Canon Inc Information processor and method for processing information
RU2075980C1 (en) 1996-01-18 1997-03-27 Акционерное общество открытого типа "Завод "Компонент" Electrostimulator of gastrointestinal tract
SE9600389D0 (en) 1996-02-02 1996-02-02 Pacesetter Ab Medical Device Used to Stimulate tissue
US6066163A (en) 1996-02-02 2000-05-23 John; Michael Sasha Adaptive brain stimulation method and system
US5651378A (en) 1996-02-20 1997-07-29 Cardiothoracic Systems, Inc. Method of using vagal nerve stimulation in surgery
US5913876A (en) 1996-02-20 1999-06-22 Cardiothoracic Systems, Inc. Method and apparatus for using vagus nerve stimulation in surgery
US20030167476A1 (en) 1996-03-26 2003-09-04 Conklin Bruce R. Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand
US5683431A (en) 1996-03-27 1997-11-04 Medtronic, Inc. Verification of capture by sensing evoked response across cardioversion electrodes
WO1997036916A1 (en) 1996-03-29 1997-10-09 The University Of Medicine And Dentistry Of New Jersey dUTPASE, ITS ISOFORMS, AND DIAGNOSTIC AND OTHER USES
WO1997036646A1 (en) 1996-04-01 1997-10-09 Valery Ivanovich Kobozev Electrical gastro-intestinal tract stimulator
US5782876A (en) 1996-04-15 1998-07-21 Medtronic, Inc. Method and apparatus using windows and an index value for identifying cardic arrhythmias
US5792198A (en) 1996-04-30 1998-08-11 Nappholz; Tibor A. Auto adaptation of RR interval in implantable pacemaker
US5683429A (en) 1996-04-30 1997-11-04 Medtronic, Inc. Method and apparatus for cardiac pacing to prevent atrial fibrillation
US5690691A (en) 1996-05-08 1997-11-25 The Center For Innovative Technology Gastro-intestinal pacemaker having phased multi-point stimulation
US6128007A (en) 1996-07-29 2000-10-03 Motorola, Inc. Method and apparatus for multi-mode handwritten input and hand directed control of a computing device
US5911223A (en) 1996-08-09 1999-06-15 Massachusetts Institute Of Technology Introduction of modifying agents into skin by electroporation
US6295470B1 (en) 1996-08-19 2001-09-25 The Mower Family Chf Treatment Irrevocable Trust Antitachycardial pacing
US6141587A (en) 1996-08-19 2000-10-31 Mower Family Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US6136019A (en) 1996-08-19 2000-10-24 Mower Family Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6411847B1 (en) 1996-08-19 2002-06-25 Morton M. Mower Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate
US6141586A (en) 1996-08-19 2000-10-31 Mower Family Chf Treatment Irrevocable Trust Method and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates
US5755740A (en) 1996-08-22 1998-05-26 Nappholz; Tibor Pacemaker with automatic calibration of the response of multiple sensors
AU4107297A (en) 1996-09-05 1998-03-26 Governors Of The University Of Alberta, The Gastro-intestinal electrical pacemaker
US6298268B1 (en) 1996-09-16 2001-10-02 Impulse Dynamics N.V. Cardiac output controller
US6463324B1 (en) 1996-09-16 2002-10-08 Impulse Dynamics N. V. Cardiac output enhanced pacemaker
EP1011795B1 (en) 1996-09-16 2010-03-10 Impulse Dynamics N.V. Cardiac output controller
IL119261D0 (en) 1996-09-17 1996-12-05 New Technologies Sa Ysy Ltd Electrical muscle controller
US5782881A (en) 1996-09-20 1998-07-21 Lu; Richard Pacemaker with safety pacing
US5797967A (en) 1996-09-27 1998-08-25 Cardiac Pacemakers, Inc. System and method to reduce defibrillation requirements
US5800464A (en) 1996-10-03 1998-09-01 Medtronic, Inc. System for providing hyperpolarization of cardiac to enhance cardiac function
US5814079A (en) 1996-10-04 1998-09-29 Medtronic, Inc. Cardiac arrhythmia management by application of adnodal stimulation for hyperpolarization of myocardial cells
TW408277B (en) 1996-11-15 2000-10-11 Alps Electric Co Ltd Small current detector circuit and locator device using the same
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US6002594A (en) 1996-12-20 1999-12-14 Logitech, Inc. Flexible touchpad circuit with mounted circuit board
US6151586A (en) 1996-12-23 2000-11-21 Health Hero Network, Inc. Computerized reward system for encouraging participation in a health management program
US6086582A (en) 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US5954761A (en) 1997-03-25 1999-09-21 Intermedics Inc. Implantable endocardial lead assembly having a stent
US5792189A (en) 1997-04-04 1998-08-11 The Research Foundation Of State University Of New York Defibrillation utilizing the dominant frequency of fibrillation
US5836994A (en) 1997-04-30 1998-11-17 Medtronic, Inc. Method and apparatus for electrical stimulation of the gastrointestinal tract
US6381495B1 (en) 1997-05-28 2002-04-30 Transneuronix, Inc. Medical device for use in laparoscopic surgery
US6261280B1 (en) 1999-03-22 2001-07-17 Medtronic, Inc Method of obtaining a measure of blood glucose
US6093167A (en) 1997-06-16 2000-07-25 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US5919216A (en) 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
US5807234A (en) 1997-06-27 1998-09-15 Pacesetter, Inc. Myostimulator control using metabolic demand and muscle performance
DE69737367T2 (en) 1997-07-16 2007-10-31 Metacure N.V., Willemstad Means for controlling a smooth muscle
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US20040249421A1 (en) 2000-09-13 2004-12-09 Impulse Dynamics Nv Blood glucose level control
US20050095227A1 (en) 1997-07-22 2005-05-05 The General Hospital Corporation Treating heart failure
CA2306856A1 (en) 1997-10-23 1999-04-29 H.B. Fuller Licensing & Financing, Inc. Hot melt pressure sensitive adhesive which exhibits minimal staining
US6180082B1 (en) 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
ID27614A (en) 1997-11-28 2001-04-12 Masayuki Matsuura Method and apparatus for wave therapy
US6392636B1 (en) 1998-01-22 2002-05-21 Stmicroelectronics, Inc. Touchpad providing screen cursor/pointer movement control
US6067470A (en) 1998-03-05 2000-05-23 Mower Family Chf Treatment Irrevocable Trust System and method for multiple site biphasic stimulation to revert ventricular arrhythmias
US6278443B1 (en) 1998-04-30 2001-08-21 International Business Machines Corporation Touch screen with random finger placement and rolling on screen to control the movement of information on-screen
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
IL125424D0 (en) 1998-07-20 1999-03-12 New Technologies Sa Ysy Ltd Pacing with hemodynamic enhancement
US6949081B1 (en) 1998-08-26 2005-09-27 Non-Invasive Technology, Inc. Sensing and interactive drug delivery
JP4142175B2 (en) 1998-10-20 2008-08-27 松下電器産業株式会社 The graphical user interface device
US6587721B1 (en) 1998-11-06 2003-07-01 Impulse Dynamics N.V. Trigger-based regulation of excitable tissue control of the heart
US6292693B1 (en) 1998-11-06 2001-09-18 Impulse Dynamics N.V. Contractility enhancement using excitable tissue control and multi-site pacing
US6463323B1 (en) 1998-11-12 2002-10-08 Em Vascular, Inc. Electrically mediated angiogenesis
AT250784T (en) 1998-11-27 2003-10-15 Synaptics Uk Ltd position sensor
EP1153404B1 (en) 1999-01-26 2011-07-20 QRG Limited Capacitive sensor and array
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
AU2000273097A8 (en) 2000-03-05 2001-11-29
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
AU3931300A (en) 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Methods for identifying pathway-specific reporters and target genes, and uses thereof
US6292704B1 (en) 1999-05-25 2001-09-18 Impulse Dynamics N. V. High capacitance myocardial electrodes
US6285906B1 (en) 1999-05-26 2001-09-04 Impulse Dynamics N. V. Muscle contraction assist device
US7190997B1 (en) 1999-06-04 2007-03-13 Impulse Dynamics Nv Drug delivery device
US7092753B2 (en) 1999-06-04 2006-08-15 Impulse Dynamics Nv Drug delivery device
US6233487B1 (en) 1999-06-08 2001-05-15 Impulse Dynamics N.V. Apparatus and method for setting the parameters of an alert window used for timing the delivery of ETC signals to a heart under varying cardiac conditions
US6296693B1 (en) 1999-09-17 2001-10-02 Mccarthy Walton W. Life cell
US7027863B1 (en) 1999-10-25 2006-04-11 Impulse Dynamics N.V. Device for cardiac therapy
US6587093B1 (en) 1999-11-04 2003-07-01 Synaptics Incorporated Capacitive mouse
JP2001142639A (en) 1999-11-15 2001-05-25 Pioneer Electronic Corp Touch panel device
US6417846B1 (en) 2000-02-02 2002-07-09 Lee Si-Ken Multifunction input device
US6919205B2 (en) 2000-02-23 2005-07-19 The Trustees Of The University Of Pennsylvania Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US6612983B1 (en) 2000-03-28 2003-09-02 Medtronic, Inc. Pancreatic secretion response to stimulation test protocol
CN1277589C (en) 2000-05-31 2006-10-04 超治疗股份有限公司 Electropancreatography
JP3910019B2 (en) 2000-07-04 2007-04-25 アルプス電気株式会社 Input device
US6555235B1 (en) 2000-07-06 2003-04-29 3M Innovative Properties Co. Touch screen system
US6605039B2 (en) 2000-07-24 2003-08-12 Medtronic, Inc. Cell-based biosensors suitable for implantable medical device applications
US6634895B2 (en) 2000-07-28 2003-10-21 Cooper Technologies Company Adapter for track lighting systems
US20020081732A1 (en) 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
EP1326675B1 (en) 2000-09-07 2011-04-13 Mann Medical Research Organization Apparatus for control of bowel function
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
US20020072780A1 (en) 2000-09-26 2002-06-13 Transneuronix, Inc. Method and apparatus for intentional impairment of gastric motility and /or efficiency by triggered electrical stimulation of the gastrointestinal tract with respect to the intrinsic gastric electrical activity
US6567700B1 (en) 2000-10-19 2003-05-20 Robert Turcott Implantable cardiac stimulation device and method which optimizes pacing effectiveness
US7440806B1 (en) 2000-11-21 2008-10-21 Boston Scientific Neuromodulation Corp. Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
US6600953B2 (en) 2000-12-11 2003-07-29 Impulse Dynamics N.V. Acute and chronic electrical signal therapy for obesity
US6484057B2 (en) 2000-12-21 2002-11-19 Uab Research Foundation Pacing methods and devices for treating cardiac arrhythmias and fibrillation
JP4246492B2 (en) 2001-01-05 2009-04-02 メタキュアー ナームロゼ フェンノートシャップ Regulation of eating habits
US6570557B1 (en) 2001-02-10 2003-05-27 Finger Works, Inc. Multi-touch system and method for emulating modifier keys via fingertip chords
US6583676B2 (en) 2001-06-20 2003-06-24 Apple Computer, Inc. Proximity/touch detector and calibration circuit
US20030100889A1 (en) 2001-07-05 2003-05-29 Nicolas Duverger Method of administration of a gene of interest to a vascular tissue
US20070060812A1 (en) 2001-11-29 2007-03-15 Metacure N.V. Sensing of pancreatic electrical activity
US6762752B2 (en) 2001-11-29 2004-07-13 N-Trig Ltd. Dual function input device and method
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US20030188899A1 (en) 2002-04-09 2003-10-09 Ching-Chuan Chao Prepositive electro-magnetic tablet with transparent antenna
US6652444B1 (en) 2002-08-13 2003-11-25 Jesse Ross Supplemental diabetic treatment method
US6875605B1 (en) 2002-08-21 2005-04-05 Florida State University Research Foundation, Inc. Modular cell culture bioreactor and associated methods
AT510253T (en) 2002-08-29 2011-06-15 N trig ltd transparent digitizer
KR100459230B1 (en) 2002-11-14 2004-12-03 엘지.필립스 엘시디 주식회사 touch panel for display device
US20040106954A1 (en) 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
US20040158289A1 (en) 2002-11-30 2004-08-12 Girouard Steven D. Method and apparatus for cell and electrical therapy of living tissue
CN102156571B (en) 2003-02-10 2013-07-24 N-特莱格有限公司 Touch detection for a digitizer
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US7529592B2 (en) 2003-04-11 2009-05-05 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with temporary pharmacological agents
EP1648558A4 (en) 2003-06-13 2015-05-27 Biocontrol Medical B C M Ltd Applications of vagal stimulation
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US7534775B2 (en) 2004-04-08 2009-05-19 Sangamo Biosciences, Inc. Methods and compositions for modulating cardiac contractility
US7663607B2 (en) 2004-05-06 2010-02-16 Apple Inc. Multipoint touchscreen
EP1796529B1 (en) 2004-09-08 2016-02-03 Olympus Corporation Capsule type medical device

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4947A (en) * 1847-02-01 Apparatus for closing doors
US3572345A (en) * 1965-10-13 1971-03-23 Philips Corp Strap for a heart stimulator
US6343232B1 (en) * 1966-08-19 2002-01-29 Mower Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US3651805A (en) * 1969-05-12 1972-03-28 Draegerwerk Ag Anesthetic vaporizer
US3651806A (en) * 1969-10-24 1972-03-28 Philip I Hirshberg Method and apparatus for administering digitalizing medications
US3933147A (en) * 1970-04-02 1976-01-20 Vall Wilbur E Du Apparatus and method for treating disorders in the region of the pubococcygeous muscle
US3942536B1 (en) * 1971-03-15 1987-03-24
US3942536A (en) * 1971-03-15 1976-03-09 Mieczyslaw Mirowski Cardioverting device having single intravascular catheter electrode system and method for its use
US3796221A (en) * 1971-07-07 1974-03-12 N Hagfors Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means
US3944740A (en) * 1973-07-31 1976-03-16 Fujitsu Limited Coordinate position information output device
US4572191B1 (en) * 1974-04-25 2000-10-24 Mirowski Miecyslaw Command atrial cardioverter
US4572191A (en) * 1974-04-25 1986-02-25 Mieczyslaw Mirowski Command atrial cardioverter
US4184493A (en) * 1975-09-30 1980-01-22 Mieczyslaw Mirowski Circuit for monitoring a heart and for effecting cardioversion of a needy heart
US4315503A (en) * 1976-11-17 1982-02-16 Electro-Biology, Inc. Modification of the growth, repair and maintenance behavior of living tissues and cells by a specific and selective change in electrical environment
US4369791A (en) * 1979-10-01 1983-01-25 Medtronic, Inc. Body implantable electrode
US4312354A (en) * 1980-02-04 1982-01-26 Arco Medical Products Company Pacemaker with circuit for pulse width modulating stimulus pulses in accordance with programmed parameter control states
US4639720A (en) * 1981-01-12 1987-01-27 Harris Corporation Electronic sketch pad
US4428366A (en) * 1981-05-06 1984-01-31 Alfred B. Kurtz Electromagnetic apparatus and method for the reduction of serum glucose levels
US4651716A (en) * 1982-12-03 1987-03-24 Canadian Patents And Development Limited Method and device for enhancement of cardiac contractility
US4506608A (en) * 1983-01-07 1985-03-26 Electrodyne Research Corp. Unfired drying and sorting apparatus for preparation of solid fuel and other solid material
US4566456A (en) * 1984-10-18 1986-01-28 Cordis Corporation Apparatus and method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output
US4637397A (en) * 1985-05-30 1987-01-20 Case Western Reserve University Triphasic wave defibrillation
US4726379A (en) * 1985-11-14 1988-02-23 Cardiac Control Systems, Inc. Cardiac pacer with switching circuit for isolation
US4717581A (en) * 1986-02-06 1988-01-05 Eic Laboratories, Inc. Iridium oxide coated electrodes for neural stimulation
US4998532A (en) * 1986-05-23 1991-03-12 Lti Biomedical, Inc. Portable electro-therapy system
US4726279A (en) * 1986-11-12 1988-02-23 United Technologies Corporation Wake stabilized supersonic combustion ram cannon
US4988837A (en) * 1987-12-25 1991-01-29 Wacom Co., Ltd. Position detecting device
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
US5002052A (en) * 1988-08-29 1991-03-26 Intermedics, Inc. System and method for detection and treatment of ventricular arrhythmias
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5097833A (en) * 1989-09-19 1992-03-24 Campos James M Transcutaneous electrical nerve and/or muscle stimulator
US4996984A (en) * 1989-09-26 1991-03-05 Eli Lilly And Company Defibrillation method
US5402151A (en) * 1989-10-02 1995-03-28 U.S. Philips Corporation Data processing system with a touch screen and a digitizing tablet, both integrated in an input device
US5097832A (en) * 1990-03-09 1992-03-24 Siemens-Pacesetter, Inc. System and method for preventing false pacemaker pvc response
US4998531A (en) * 1990-03-28 1991-03-12 Cardiac Pacemakers, Inc. Implantable N-phasic defibrillator output bridge circuit
US5386835A (en) * 1990-03-30 1995-02-07 Elphick; Kevin J. Barrier means
US5097843A (en) * 1990-04-10 1992-03-24 Siemens-Pacesetter, Inc. Porous electrode for a pacemaker
US5083564A (en) * 1990-06-01 1992-01-28 Board Of Regents Of The University Of Oklahoma Method for alleviating and diagnosing symptoms of heart block
US5499971A (en) * 1990-06-15 1996-03-19 Cortrak Medical, Inc. Method for iontophoretically delivering drug adjacent to a heart
US5286254A (en) * 1990-06-15 1994-02-15 Cortrak Medical, Inc. Drug delivery apparatus and method
US5087243A (en) * 1990-06-18 1992-02-11 Boaz Avitall Myocardial iontophoresis
US5085218A (en) * 1990-08-31 1992-02-04 Cardiac Pacemakers, Inc. Bipolar myocardial positive fixation lead with improved sensing capability
US5281219A (en) * 1990-11-23 1994-01-25 Medtronic, Inc. Multiple stimulation electrodes
US5188104A (en) * 1991-02-01 1993-02-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5482052A (en) * 1991-04-29 1996-01-09 Lerner; Eduard N. Method and apparatus for determining sensory functions
US5398683A (en) * 1991-05-24 1995-03-21 Ep Technologies, Inc. Combination monophasic action potential/ablation catheter and high-performance filter system
US5185620A (en) * 1991-08-22 1993-02-09 Cooper George F Eyeglass system
US5381160A (en) * 1991-09-27 1995-01-10 Calcomp Inc. See-through digitizer with clear conductive grid
US5184616A (en) * 1991-10-21 1993-02-09 Telectronics Pacing Systems, Inc. Apparatus and method for generation of varying waveforms in arrhythmia control system
US5184620A (en) * 1991-12-26 1993-02-09 Marquette Electronics, Inc. Method of using a multiple electrode pad assembly
US5284491A (en) * 1992-02-27 1994-02-08 Medtronic, Inc. Cardiac pacemaker with hysteresis behavior
US5501662A (en) * 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5495077A (en) * 1992-06-08 1996-02-27 Synaptics, Inc. Object position and proximity detector
US5861583A (en) * 1992-06-08 1999-01-19 Synaptics, Incorporated Object position detector
US5292344A (en) * 1992-07-10 1994-03-08 Douglas Donald D Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port
US5865787A (en) * 1992-10-06 1999-02-02 Cortrak Medical, Inc. Simultaneous cardiac pacing and local drug delivery
US5397344A (en) * 1992-12-22 1995-03-14 Schering Aktiengesellschaft Methods of and apparatus for measuring uterine electrical and mechanical activity
US5386837A (en) * 1993-02-01 1995-02-07 Mmtc, Inc. Method for enhancing delivery of chemotherapy employing high-frequency force fields
US5391199A (en) * 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US5489293A (en) * 1993-08-31 1996-02-06 Ventritex, Inc. Method and apparatus for treating cardiac tachyarrhythmia
US5601609A (en) * 1993-09-15 1997-02-11 Pacesetter, Inc. Implantable cardiac stimulating device and method for administering synchronized cardioversion shock therapy to provide preemptive depolarization
US5391192A (en) * 1994-03-04 1995-02-21 Telectronics Pacing Systems, Inc. Automatic ventricular pacing pulse threshold determination utilizing an external programmer and a surface electrocardiogram
US5601611A (en) * 1994-08-05 1997-02-11 Ventritex, Inc. Optical blood flow measurement apparatus and method and implantable defibrillator incorporating same
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US5713924A (en) * 1995-06-27 1998-02-03 Medtronic, Inc. Defibrillation threshold reduction system
US6032074A (en) * 1995-10-11 2000-02-29 Trustees Of Boston University Method and apparatus for improving the function of sensory cells
US6363279B1 (en) * 1996-01-08 2002-03-26 Impulse Dynamics N.V. Electrical muscle controller
US7167748B2 (en) * 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US6032672A (en) * 1996-02-20 2000-03-07 Cardiothoracic Systems, Inc. Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery
US5713929A (en) * 1996-05-03 1998-02-03 Medtronic, Inc. Arrhythmia and fibrillation prevention pacemaker using ratchet up and decay modes of operation
US5720768A (en) * 1996-05-22 1998-02-24 Sulzer Intermedics Inc. Dual chamber pacing with interchamber delay
US6337995B1 (en) * 1996-08-19 2002-01-08 Mower Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention for atrial fibrillation
US5871506A (en) * 1996-08-19 1999-02-16 Mower; Morton M. Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US6178351B1 (en) * 1996-08-19 2001-01-23 The Mower Family Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US6341235B1 (en) * 1996-08-19 2002-01-22 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US5713935A (en) * 1996-08-23 1998-02-03 Sulzer Intermedics Inc. Method and apparatus for monitored biphasic cardiac impedance sensing
US20070027490A1 (en) * 1996-09-16 2007-02-01 Shlomo Ben-Haim Fencing of Cardiac Muscles
US6026326A (en) * 1997-01-13 2000-02-15 Medtronic, Inc. Apparatus and method for treating chronic constipation
US5861014A (en) * 1997-04-30 1999-01-19 Medtronic, Inc. Method and apparatus for sensing a stimulating gastrointestinal tract on-demand
US7006871B1 (en) * 1997-07-16 2006-02-28 Metacure N.V. Blood glucose level control
US6037882A (en) * 1997-09-30 2000-03-14 Levy; David H. Method and apparatus for inputting data to an electronic system
US6023640A (en) * 1999-03-29 2000-02-08 Ross; Jesse Method contributing to obviating male impotency
US6684104B2 (en) * 1999-04-14 2004-01-27 Transneuronix, Inc. Gastric stimulator apparatus and method for installing
US7171263B2 (en) * 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US6504530B1 (en) * 1999-09-07 2003-01-07 Elo Touchsystems, Inc. Touch confirming touchscreen utilizing plural touch sensors
US20020026141A1 (en) * 1999-11-04 2002-02-28 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6853862B1 (en) * 1999-12-03 2005-02-08 Medtronic, Inc. Gastroelectric stimulation for influencing pancreatic secretions
US20020010492A1 (en) * 2000-03-06 2002-01-24 Medtronic, Inc. Subthreshold stimulator for angiogenesis
US20050021101A1 (en) * 2000-04-11 2005-01-27 Jiande Chen Gastrointestinal electrical stimulation
US6507093B2 (en) * 2000-04-19 2003-01-14 Nec Corporation Lead frame for fabricating surface mount type semiconductor devices with high reliability
US6690156B1 (en) * 2000-07-28 2004-02-10 N-Trig Ltd. Physical object location apparatus and method and a graphic display device using the same
US6505745B1 (en) * 2000-08-01 2003-01-14 Richard E Anderson Holder for articles such as napkins
US20030018367A1 (en) * 2001-07-23 2003-01-23 Dilorenzo Daniel John Method and apparatus for neuromodulation and phsyiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20030028221A1 (en) * 2001-07-31 2003-02-06 Qingsheng Zhu Cardiac rhythm management system for edema
US20070027487A1 (en) * 2003-03-10 2007-02-01 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US20050033396A1 (en) * 2003-04-10 2005-02-10 Peter Ospyka Cardiac electrode anchoring system
US20100016923A1 (en) * 2004-03-10 2010-01-21 Impulse Dynamics Nv Protein activity modification
US20060036126A1 (en) * 2004-08-16 2006-02-16 Jeffrey Ross Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US20100035963A1 (en) * 2005-09-09 2010-02-11 Ayelet Chajut Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease
US20130009639A1 (en) * 2011-06-13 2013-01-10 Toshiba Medical Systems Corporation Magnetic resonance imaging apparatus and load calculation method of a gradient magnetic field generation system

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US8260416B2 (en) 1996-01-08 2012-09-04 Impulse Dynamics, N.V. Electrical muscle controller
US8301247B2 (en) 1996-01-08 2012-10-30 Impulse Dynamics, N.V. Electrical muscle controller
US8311629B2 (en) 1996-01-08 2012-11-13 Impulse Dynamics, N.V. Electrical muscle controller
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
US8326416B2 (en) 2003-03-10 2012-12-04 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy

Also Published As

Publication number Publication date
US8825152B2 (en) 2014-09-02
US20030040777A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
US7561923B2 (en) Method and apparatus for controlling autonomic balance using neural stimulation
US8214040B2 (en) Intermittent stress augmentation pacing for cardioprotective effect
US5156154A (en) Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniques
AU2007290727B2 (en) System for neural stimulation
US5902324A (en) Bi-atrial and/or bi-ventricular sequential cardiac pacing systems
US7512440B2 (en) Ventricular pacing
US6122553A (en) Method and apparatus for treating cardiac arrhythmia
CN1206006C (en) Pacing with hemodynamic enhancement and related method
JP4589365B2 (en) Cardiac output controller
US5188106A (en) Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound
US6415183B1 (en) Method and apparatus for diaphragmatic pacing
EP0688579B1 (en) Device for heart therapy
EP2263748B1 (en) Multi-site ventricular pacing device with parasympathetic stimulation
EP2114519B1 (en) Neural stimulation systems
US8909337B2 (en) System to treat AV-conducted ventricular tachyarrhythmia
US8306616B2 (en) Electrical muscle controller
EP0547733B1 (en) An arrhythmia control pacer using skeletal muscle cardiac graft stimulation
US5235976A (en) Method and apparatus for managing and monitoring cardiac rhythm using active time as the controlling parameter
JP4515540B2 (en) Stabilization of the heart rhythm to use the neuro-Saibane tic prosthesis
US6484057B2 (en) Pacing methods and devices for treating cardiac arrhythmias and fibrillation
US6363279B1 (en) Electrical muscle controller
EP1011432B1 (en) Ischemia detector
EP0647149B1 (en) Apparatus for treatment of heart disorders
US7321793B2 (en) Vagal stimulation for atrial fibrillation therapy
EP1514577A1 (en) Electrical muscle controller

Legal Events

Date Code Title Description
AS Assignment

Owner name: IMPULSE DYNAMICS N.V., NETHERLANDS ANTILLES

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHERMER, ITZIK;FELZEN, BELLA;DARVISH, NISSIM;AND OTHERS;REEL/FRAME:013873/0884;SIGNING DATES FROM 20020922 TO 20021007

Owner name: IMPULSE DYNAMICS N.V., NETHERLANDS ANTILLES

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHERMER, ITZIK;FELZEN, BELLA;DARVISH, NISSIM;AND OTHERS;SIGNING DATES FROM 20020922 TO 20021007;REEL/FRAME:013873/0884

AS Assignment

Owner name: DRUMBEAT LIMITED, IRELAND

Free format text: SECURITY INTEREST;ASSIGNOR:IMPULSE DYNAMICS N.V.;REEL/FRAME:019448/0301

Effective date: 20031217

AS Assignment

Owner name: BANK HAPOALIM B.M., ISRAEL

Free format text: SECURITY AGREEMENT;ASSIGNOR:IMPULSE DYNAMICS N.V.;REEL/FRAME:019773/0300

Effective date: 20070627

AS Assignment

Owner name: JOHNSON & JOHNSON DEVELOPMENT CORPORATION, NEW JER

Free format text: SECURITY AGREEMENT;ASSIGNOR:IMPULSE DYNAMICS N.V.;REEL/FRAME:019825/0338

Effective date: 20070627

AS Assignment

Owner name: MEDINVEST CAPITAL S.A R.L., LUXEMBOURG

Free format text: SECURITY AGREEMENT;ASSIGNOR:IMPULSE DYNAMICS N.V.;REEL/FRAME:022408/0930

Effective date: 20090309

Owner name: MEDINVEST CAPITAL S.A R.L.,LUXEMBOURG

Free format text: SECURITY AGREEMENT;ASSIGNOR:IMPULSE DYNAMICS N.V.;REEL/FRAME:022408/0930

Effective date: 20090309

AS Assignment

Owner name: SANDLEFORD PARK LIMITED, AS SECURITY AGENT, VIRGIN

Free format text: ASSIGNMENT OF TRADEMARK AND PATENT SECURITY AGREEMENT;ASSIGNORS:MEDINVEST CAPITAL S.A.R.L.;MORGAN STANLEY BANK INTERNATIONAL LIMITED;REEL/FRAME:035387/0041

Effective date: 20150331

MAFP

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551)

Year of fee payment: 4